In this issue:
Systemic psoriasis therapy and COVID-19 outcomes
Psoriatic arthritis assessment and documentation
Mortality risk in generalised pustular psoriasis
Lifestyle metabolites and risk of late-onset psoriasis
Drug survival of systemic treatments in paediatric psoriasis
Route of methotrexate administration in psoriasis
Apremilast for genital psoriasis
Smoking cessation, weight change and psoriasis risk
Cumulative life course impairment in psoriasis
Long-term patient-reported outcomes with bimekizumab
Please login below to download this issue (PDF)